2,461 material Form 8-K filings that 2,078 companies we cover made with the SEC in November 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 1,081 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Lemonade reported third-quarter 2026 revenue of $336.1 million, up 73% from a year earlier, and raised its full-year 2026 revenue and gross earned premium guidance. Net loss widened to $43.7 million, or $0.56 per share, from $37.5 million, mainly due to higher stock-based compensation and interest expense, so the top-line gains came with a larger loss for shareholders.
Third-quarter revenue was $336.1 million, up $141.6 million or 73%; in force premium rose 34% to $1.55 billion.
Net loss was $43.7 million ($0.56 per share), compared with $37.5 million ($0.51 per share) in Q3 2025.
Adjusted EBITDA loss narrowed to $20.4 million from $25.6 million; the company reiterated expected positive Adjusted EBITDA in Q4 2026.
Full-year 2026 revenue guidance was raised to $1,231-$1,235 million; in force premium guidance was reiterated at $1,632-$1,639 million.
LifeStance reported third quarter 2026 revenue of $455.9 million, up 25%, and net income of $22.4 million, compared with $1.1 million a year earlier. The company raised its full-year 2026 guidance for revenue, Center Margin and Adjusted EBITDA, which points to stronger expected results for shareholders.
Q3 2026 revenue $455.9 million, up 25% from $363.8 million; net income $22.4 million versus $1.1 million
Adjusted EBITDA $68.4 million, up 70%; Center Margin $161.4 million, up 38%
Full-year 2026 revenue guidance raised to $1.741 billion to $1.761 billion; Adjusted EBITDA to $242 million to $250 million
Q4 2026 guidance: revenue $446 million to $466 million; Adjusted EBITDA $56 million to $64 million
Precigen reported third quarter 2026 results for the period ended September 30, 2026. Total revenues were $74.1 million, up $71.2 million from a year earlier, mainly from commercial sales of PAPZIMEOS after its August 2025 FDA approval, and the company posted net income of $35.8 million, or $0.08 per diluted share, compared with a net loss attributable to common shareholders of $325.3 million in the prior-year quarter. Operating cash flow was positive at $11.9 million, a full quarter ahead of the company's guidance.
Total revenues $74.1 million versus $2.9 million a year earlier; PAPZIMEOS net product revenue was $72.9 million, up 37% from the prior quarter.
Net income $35.8 million, or $0.08 per diluted share, versus a prior-year net loss attributable to common shareholders of $325.3 million that included a $111.5 million warrant liability charge and a $179.0 million deemed dividend.
Net cash provided by operating activities was $11.9 million in the third quarter, which the company said was a full quarter ahead of its guidance.
Cash, cash equivalents and investments totaled $51.0 million as of September 30, 2026.
Hornbeck Offshore Services reported a third-quarter 2026 net loss of $85.7 million, or $0.40 per diluted share, on revenue of $293.3 million, up from $183.3 million in the second quarter. Results include one month of legacy Helix operations after the merger closed on September 1, 2026, and $119.8 million of merger and integration costs. The company also guided to Adjusted EBITDA of $90 million to $100 million for the fourth quarter of 2026 and $500 million to $550 million for full-year 2027.
Q3 2026 revenue was $293.3 million, up $110.0 million from the second quarter but down from $199.1 million a year earlier.
Net loss was $85.7 million, or $0.40 per diluted share, compared with net income of $11.1 million in the second quarter.
Adjusted EBITDA was $105.9 million; the company guided to $90 million to $100 million for Q4 2026 and $500 million to $550 million for 2027.
Cash of $471.6 million and total debt face value of $730.6 million as of September 30, 2026.
BuzzFeed reported third-quarter 2026 revenue of $26.0 million, down 44% from $46.3 million a year earlier, and a net loss of $18.7 million, compared with $7.4 million a year earlier. The company deferred its full-year 2026 financial outlook while it integrates the Allen Family Digital transaction and its July restructuring, which it expects to yield about $30 million in annualized savings.
Q3 2026 revenue was $26.0 million versus $46.3 million in Q3 2025, a 44% decline
Q3 2026 net loss was $18.7 million versus $7.4 million; Adjusted EBITDA was negative $4.8 million versus $0.8 million
Full-year 2026 financial outlook was deferred, with no new guidance provided
Restructuring is expected to yield about $30 million in annualized savings after cutting workforce and contractors by about 35%
EPAM reported third-quarter 2026 revenue of $1.426 billion, up 2.3% year over year, and GAAP diluted EPS of $2.53, up from $1.91. The Board replaced the prior repurchase program with a new $1.8 billion authorization through December 31, 2029, and EPAM expects to enter a $500 million accelerated share repurchase during the week of November 9, 2026, which shareholders would see as a larger capital return.
Q3 revenue $1.426 billion, up $32.1 million or 2.3%; GAAP income from operations rose 21.4% to $175.9 million
GAAP diluted EPS $2.53 vs. $1.91 a year earlier; non-GAAP diluted EPS $3.51, up 14.0%
$500 million accelerated share repurchase expected the week of November 9, 2026, funded with cash on hand and credit facility borrowings
Fourth-quarter revenue expected at $1.405 billion to $1.420 billion; cash, cash equivalents and restricted cash fell to $969.9 million as of September 30, 2026
Prospect Capital reported a net loss applicable to common shareholders of $53.4 million, or $0.10 per share, for the quarter ended September 30, 2026, compared with net income of $48.1 million, or $0.10 per share, a year earlier. Net investment income was $76.4 million, or $0.15 per common share, down from $79.4 million, or $0.17 per share, a year earlier, and net asset value per common share fell to $5.36 from $5.71 in the prior quarter and $6.45 a year earlier.
Net loss applicable to common shareholders: $(53.4) million, or $(0.10) per share, for the quarter ended September 30, 2026
Net investment income: $76.4 million, or $0.15 per share, versus $79.4 million, or $0.17 per share, a year earlier
Net asset value per common share: $5.36 at September 30, 2026, versus $5.71 at June 30, 2026 and $6.45 at September 30, 2025
Board increased the share repurchase program to up to $200.0 million on November 3, 2026; monthly common distribution declared at $0.0350 per share
Comstock Resources reported third quarter 2026 results, with production up 9% from a year earlier and natural gas and oil sales including hedging rising to $359.3 million. Net income available to the Company fell to $22.3 million from $111.1 million, and total revenues fell to $384.4 million from $447.4 million. The company also agreed on November 4, 2026 to sell non-operated interests to SOCAR for $1.65 billion in cash, expected to close by year end, and extended its bank credit facility maturity to November 15, 2028.
Net income available to the Company was $22.3 million, or $0.08 per diluted share, versus $111.1 million, or $0.40 per diluted share, in the third quarter of 2025.
Production was 122.4 Bcfe, up 9% from the third quarter of 2025; natural gas and oil sales including hedging were $359.3 million versus $335.0 million.
Gas services revenue fell to $64.5 million from $141.3 million, and total revenues and other operating income fell to $384.4 million from $447.4 million.
SOCAR purchase price is $1.65 billion, with closing expected by year end; the bank credit facility maturity was extended to November 15, 2028.
Duke Energy reported third-quarter 2026 reported and adjusted EPS of $1.99, up from $1.81 in the prior-year period, driven by infrastructure investment recovery and favorable weather. The company also narrowed its full-year 2026 adjusted EPS guidance range to $6.70 to $6.80.
Third-quarter 2026 reported and adjusted EPS was $1.99 compared to $1.81 in the third quarter of 2025.
The full-year 2026 adjusted EPS guidance range was narrowed to $6.70 to $6.80.
Electric Utilities and Infrastructure segment income rose to $1,817 million for the third quarter of 2026.
Dorian LPG reported revenues of $221.3 million for the quarter ended September 30, 2026, up 78.4% from a year earlier, driven by higher time charter equivalent rates. Net income of $213.9 million included a $63.6 million gain on vessel sales, and the company declared an irregular cash dividend of $1.25 per share, about $53.7 million in total, payable November 24, 2026.
Revenues were $221.3 million, up from $124.1 million a year earlier, with TCE rates at $96,990 per available day versus $53,725.
Net income was $213.9 million, or $4.98 per diluted share, versus $1.30 a year earlier; adjusted EPS was $3.46 versus $1.31.
Adjusted EBITDA was $242.0 million, compared with $85.7 million in the prior-year quarter.
An irregular dividend of $1.25 per share, about $53.7 million, is payable on or about November 24, 2026, to holders of record as of November 9, 2026.
Intrusion Inc. received a Nasdaq notice granting it a second 180-day period, until May 3, 2027, to regain compliance with the $1.00 minimum bid price requirement after missing the initial deadline of November 3, 2026. The stock continues to trade on the Nasdaq Capital Market under INTZ, but if the company does not regain compliance, Nasdaq will move toward delisting, and the company may need a reverse stock split.
Nasdaq granted an additional 180 calendar days, until May 3, 2027, to regain the $1.00 minimum bid price requirement.
The company did not regain compliance during the initial 180-day period, which expired November 3, 2026.
To regain compliance, the closing bid price must be at least $1.00 for 10 consecutive business days before May 3, 2027, and any reverse stock split must be completed no later than ten business days before that date.
The company makes no assurance it will regain compliance or successfully appeal any future delisting determination.
Carlyle reported unaudited third quarter 2026 results, with a U.S. GAAP net loss attributable to the company of $8 million, or $0.02 per diluted share, compared with a $0.9 million profit a year earlier. Distributable Earnings rose to $433 million, or $1.12 per share, from $368 million, or $0.96 per share, in the prior-year quarter, while Fee Related Earnings fell 6% to $293 million. Shareholders also received a $0.35 quarterly dividend declaration.
U.S. GAAP net loss attributable to The Carlyle Group Inc. was $8 million, or $0.02 per diluted share, versus $0.9 million, or $0.00 per share, in Q3 2025
Distributable Earnings were $433 million, or $1.12 per common share, versus $368 million, or $0.96, in Q3 2025
Fee Related Earnings were $293 million, down 6% from $312 million in Q3 2025
Quarterly dividend of $0.35 per share declared, payable November 23, 2026 to holders of record on November 16, 2026
HF Sinclair agreed to buy back 2,100,000 shares of its common stock from REH Advisors Inc. at $110.81 per share, for an aggregate price of approximately $233 million, funded with cash on hand. The repurchase is expected to close on or around November 6, 2026, and is made under the company's $1.5 billion share repurchase program, which leaves about $493 million of authorization remaining.
2,100,000 shares at $110.81 per share, for an aggregate price of approximately $233 million, funded with cash on hand
Stock Purchase Agreement dated November 3, 2026; expected completion on or around November 6, 2026
Made under the $1.5 billion share repurchase program authorized by the Board on August 26, 2026; about $493 million remains, and $1 billion has been repurchased to date including this transaction
Shares will be held as treasury stock; this is the twenty-fourth privately negotiated transaction between the company and REH
Seaport Entertainment Group reported third-quarter 2026 revenue of $32.7 million, down 27.4% from $45.1 million a year earlier. Its net loss attributable to common stockholders narrowed to $8.4 million, or $0.65 per share, from $33.2 million, or $2.61 per share, in the prior-year quarter. The results show lower revenue alongside a smaller loss, and the company reported $110.3 million in cash and restricted cash at September 30, 2026.
Q3 2026 total revenues were $32.7 million versus $45.1 million in Q3 2025, a decline of 27.4%.
Q3 2026 net loss attributable to common stockholders was $8.4 million ($0.65 per share), versus $33.2 million ($2.61 per share) a year earlier.
Non-GAAP adjusted net loss attributable to common stockholders was $3.0 million ($0.23 per share), versus $7.2 million ($0.57 per share).
As of September 30, 2026, the company had $38.1 million of debt at a fixed 4.9% rate, with a maturity in 2038; a conference call is set for November 5, 2026, at 8:30 AM ET.
NW Natural Holdings reported third-quarter 2026 results, with a net loss of $0.71 per share compared with a loss of $0.73 a year earlier. Nine-month EPS rose to $1.62 from $1.36, and the company raised its 2026 EPS guidance range to $3.10 to $3.20, up from the prior range of $2.95 to $3.15, which it had expected to finish in the upper half. The board also declared a quarterly dividend of $0.50 per share, described as the largest declared increase since 2012.
Q3 2026 net loss of $0.71 per share, versus a $0.73 loss in Q3 2025; consolidated net loss was $29.8 million
Nine-month 2026 EPS of $1.62, compared with $1.36 a year earlier and adjusted EPS of $1.52 for the same period in 2025
2026 EPS guidance raised to $3.10 to $3.20; long-term EPS growth target of 4% to 6% reaffirmed
Quarterly dividend of $0.50 per share, payable Nov. 13, 2026, marking the 71st consecutive year of dividend increases
Mid Penn Bancorp furnished an investor presentation under Regulation FD for use in meetings during the fourth quarter of 2026. The deck shows third-quarter 2026 net income of $21.6 million, or $0.84 per share, and core net income of $22.2 million, or $0.88 per share, with total assets of $7.1 billion at September 30, 2026.
Q3 2026 net income of $21.6 million, or $0.84 per share; core net income of $22.2 million, or $0.88 per share
Core earnings per share of $0.88 in 2026Q3 compares with $0.77 in 2025Q3 and $0.87 in 2026Q2
Board declared a quarterly cash dividend of $0.23 per share, payable November 13, 2026, to holders of record on November 2, 2026
Total assets of $7.1 billion and gross loans of $5.7 billion at September 30, 2026
Kinetik reported third quarter 2026 results, with Adjusted EBITDA of $278.1 million, up from $242.6 million a year earlier, and net income including noncontrolling interest of $50.9 million, up from $15.5 million. The company now expects full year 2026 Adjusted EBITDA at the high end of its $1.04 billion to $1.1 billion guidance range and expects capital expenditures about 5% below its $560 million guidance.
Q3 2026 total operating revenues were $569.4 million, versus $464.0 million in Q3 2025; diluted EPS attributable to Class A holders was $0.26, versus $0.03
Midstream Logistics Adjusted EBITDA was $203.6 million, a 34% year-over-year increase; Pipeline Transportation Adjusted EBITDA fell 18% to $78.5 million, mainly due to the EPIC Crude Holdings divestiture
Free Cash Flow was $87.5 million for Q3 2026 versus $13.9 million a year earlier; Net Debt was $3.94 billion at September 30, 2026
The ECCC Pipeline expansion reached final investment decision, and the company expects in-service in mid-2027
Medicus Pharma Ltd. said its wholly owned subsidiary, Skinject, Inc., entered into a non-binding letter of intent with an undisclosed special purpose acquisition company for a proposed business combination. The letter contemplates a $135 million pre-money enterprise valuation for SkinJect and concurrent equity financing, with Medicus seeking to retain majority economic and voting ownership. The terms are largely non-binding, and the company expects completion, if at all, during the first half of 2027.
Non-binding letter of intent with an undisclosed SPAC; contemplated pre-money enterprise valuation of $135 million for SkinJect
Concurrent equity financing intended to support the SKNJCT-005 study in Gorlin syndrome and preparation of a potential New Drug Application
Medicus intends to retain majority economic and voting ownership; completion anticipated during the first half of 2027 but not assured
Third quarter 2026 financial performance and business update call scheduled for November 9, 2026, at 11:30 a.m. ET
On October 30, 2026, cbdMD completed its acquisition of operating assets from Twinlab Consolidated Holdings through a court-approved creditor sale. The company assumed $1.75 million of senior secured debt owed to Akretive Holdings, LLC, and issued that creditor 2,229,805 common shares, equal to 19.9% of shares outstanding at signing, with 132,730 more shares planned subject to shareholder approval. The deal adds nutritional supplement brands and moves cbdMD beyond hemp products, but it also adds secured debt and share issuance that dilutes existing holders.
Closed October 30, 2026, after a Broward County, Florida court approved the sale as a private sale; the seller was the assignee for the benefit of creditors, Philip J. Von Kahle.
Issued 2,229,805 common shares, valued at $1.00 per share, to Akretive Holdings, LLC, representing 19.9% of shares outstanding at signing.
Assumed a $1,750,000 senior secured note bearing 9% annual interest, maturing two years after the closing date and secured by the acquired assets.
Acquired brands include Twinlab, Reserveage, Metabolife and ResVitale; 132,730 additional shares are subject to shareholder approval within 270 days of closing.
Bio Green Med Solution, Inc. filed a Form 8-K dated November 4, 2026, that lists Item 3.01 (Delisting or Listing Rule Notice) and Item 9.01 (Financial Statements and Exhibits). The text provided includes only the Item 9.01 exhibit list and signature block, so the specific exchange, rule, and deadline are not stated in the material reviewed. Because the item concerns a listing notice, shareholders should review the full filing for its terms.
Exhibit 104 is the Cover Page Interactive Data File; the text provided does not state the exchange or compliance deadline
Signed by Datuk Dr. Doris Wong Sing Ee, Chief Executive Officer and Executive Director
Nature's Sunshine reported third-quarter 2026 net sales down 9% to $116.6 million, and GAAP net income attributable to common shareholders fell to $1.9 million, or $0.11 per diluted share, from $5.3 million, or $0.30. The company cut its full-year 2026 guidance for net sales and adjusted EBITDA, citing a stronger U.S. dollar and challenges in China.
Net sales fell 9% to $116.6 million (down 7% excluding currency effects); Asia net sales fell 14.9% to $55.1 million
Full-year 2026 net sales outlook lowered to $460-470 million from $490-500 million
Full-year 2026 adjusted EBITDA outlook lowered to $44-48 million from $48-52 million
As of September 30, 2026, cash and cash equivalents were $89.4 million and the company had zero debt
Quoin Pharmaceuticals signed a sales agreement with Leerink Partners LLC that lets it sell American Depositary Shares from time to time through an at-the-market offering. Leerink would receive 3.0% of gross sale proceeds, and the filing does not state a dollar amount or number of shares to be sold, so the potential dilution to shareholders is not quantified.
Sales agreement with Leerink Partners LLC dated November 4, 2026; each ADS represents 35 ordinary shares.
Leerink Partners would be paid 3.0% of gross sale proceeds from ADSs sold through it.
Sales are made under Form S-3 (File No. 333-299668), declared effective November 4, 2026; the filing states no aggregate offering size.
Either party may suspend or terminate the agreement at any time upon notice.
Genco Shipping & Trading reported third-quarter 2026 net income of $38.0 million, or $0.85 per diluted share, compared with a net loss of $1.1 million a year earlier, and declared a record $1.05 per share dividend. The company reiterated a projected Q4 2026 dividend of greater than $1 per share, but that projection depends on current fixtures and the forward freight agreement curve, which the filing says is subject to change.
Q3 2026 net income of $38.0 million, or $0.85 diluted EPS, versus a net loss of $1.1 million in Q3 2025
Record Q3 2026 dividend of $1.05 per share, payable on or about November 23, 2026 to holders of record as of November 16, 2026
Voyage revenues of $151.9 million versus $79.9 million a year earlier; adjusted EBITDA of $68.1 million, up 214% year over year
Q4 2026 projected dividend reiterated at greater than $1 per share; Q4 fixtures cover 66% of owned fleet available days
Stoneridge reported third-quarter 2026 GAAP net sales of $155.8 million, up from $138.6 million a year earlier, but a $24.2 million arbitration award recorded as a reduction to sales pushed its net loss from continuing operations to $22.9 million, or $0.81 per diluted share, versus a $8.9 million loss, or $0.32 per share, a year earlier. The company raised its 2026 adjusted revenue guidance to $690 million to $700 million while expecting adjusted EBITDA at the bottom of its prior $20 million to $25 million range.
Q3 2026 GAAP net loss from continuing operations was $22.9 million, or $0.81 per diluted share, compared with $8.9 million, or $0.32 per share, in Q3 2025.
The $24.2 million pre-tax charge stems from an adverse ruling received on November 2, 2026 in an arbitration over legacy PM sensor warranty claims; the company disagrees with the ruling and is evaluating its options.
Adjusted 2026 revenue guidance was raised to $690 million to $700 million from $645 million to $670 million; adjusted EBITDA guidance of $20 million to $25 million is now expected at the bottom end.
As of September 30, 2026, net debt was $80.2 million, and the Credit Facility matures on July 1, 2027.
Black Hills reported third-quarter 2026 GAAP net income available for common stock of $41.0 million, or $0.54 per diluted share, up from $24.9 million, or $0.34, a year earlier. Adjusted EPS was $0.57, up from $0.45, and the company reaffirmed its 2026 adjusted EPS guidance of $4.25 to $4.45, excluding merger-related costs. The pending merger with NorthWestern Energy still requires a final approval from the Montana Public Service Commission.
Q3 2026 revenue was $466.1 million, compared with $430.2 million in Q3 2025.
GAAP EPS was $0.54 versus $0.34; adjusted EPS was $0.57 versus $0.45.
2026 adjusted EPS guidance of $4.25 to $4.45 was reaffirmed, excluding merger-related costs.
The NorthWestern Energy merger is expected to close by year-end 2026, subject to Montana approval.
ATN International reported third quarter 2026 results with revenue flat at $183.2 million and Adjusted EBITDA flat at $50 million, while operating income rose 32% to $12.9 million and diluted EPS rose to $1.09 from $0.18. The company now expects 2026 Adjusted EBITDA at the high end of, or modestly above, its previous $183 million to $193 million range, though the US Tower Portfolio Sale weighed on US results.
Diluted EPS increased to $1.09 from $0.18, primarily reflecting higher operating income, lower interest expense and a greater tax benefit.
Revenue was stable at $183.2 million; International Telecom revenue rose 2% to $96.9 million while US Telecom revenue fell 2% to $86.3 million.
2026 Adjusted EBITDA is now expected at the high end of, or modestly above, the previous $183 million to $193 million range; capital expenditure guidance of $105 million to $115 million is unchanged.
Cash, cash equivalents and restricted cash totaled $351.5 million at September 30, 2026; the Net Leverage Ratio improved to 0.94x from 2.36x at December 31, 2025.
RLJ Lodging Trust reported third-quarter 2026 total revenue of $354.5 million, up 7.4%, and net income of $4.6 million, compared with a net loss of $3.8 million a year earlier. The company raised its full-year 2026 outlook, including Adjusted FFO per diluted share of $1.47 to $1.51, citing strong third-quarter results and preliminary October results.
Comparable RevPAR rose 9.7% to $153.36 in the third quarter, driven by a 6.4% increase in ADR and a 230 basis point increase in occupancy.
Adjusted EBITDA was $85.2 million, up 17.3%, and Adjusted FFO per diluted share was $0.34, up 25.9% from $0.27.
Full-year 2026 outlook: Adjusted EBITDA of $352 million to $358 million and Comparable Hotel EBITDA of $377 million to $383 million.
In October 2026, the company sold seven hotels near Chicago Midway Airport for $110.0 million, and it reported approximately $448.3 million of unrestricted cash as of September 30, 2026.
Solaris Energy Infrastructure reported third quarter 2026 revenue of approximately $341 million, up 55% from the second quarter, with net income of $39 million and diluted EPS of $0.42 versus $0.26 in the prior quarter. The company raised its fourth quarter 2026 and first quarter 2027 Adjusted EBITDA guidance and signed a new 15-year, 900 MW power contract, which gives shareholders higher reported results and a larger contracted backlog.
Q3 2026 revenue of approximately $341 million, compared with $166.8 million in Q3 2025; Adjusted EBITDA of approximately $136 million, up 26% sequentially
Q4 2026 Adjusted EBITDA guidance raised to $165-185 million from $145-180 million; Q1 2027 guidance raised to $220-260 million from $200-240 million
New 15-year power contract signed October 29, 2026 for approximately 900 MW, with deployments expected to begin in 1H 2027
Quarterly dividend of $0.12 per share declared October 27, 2026, payable December 18, 2026
Nasdaq has started procedures to delist Cayson Acquisition Corp's securities after the company did not show it met the Minimum Total Holders Rule by its extended October 26, 2026 deadline. The company has appealed the determination to keep its listing and says it expects to provide documentation that could make the matter moot before an appeal hearing is scheduled.
Nasdaq Listing Rule 5450(a)(2) requires at least 400 Total Holders, counting beneficial holders and holders of record.
Nasdaq extended the compliance deadline to October 26, 2026, but the company did not evidence compliance within that period.
Nasdaq notified the company on October 29, 2026 that it has initiated delisting procedures.
The company has appealed, and its appeal right ran through November 5, 2026.
National Healthcare Properties reported third quarter 2026 results, with net income attributable to common stockholders of $0.24 per diluted share, compared with a loss of $0.56 a year earlier, and revenue from tenants of $103.1 million, up from $86.0 million. However, Nareit FFO fell 43.5% to $0.13 per diluted share and Normalized FFO fell 29.6% to $0.19, and the company raised its full-year 2026 SHOP Same Store Cash NOI growth guidance to 16.5% to 18.5% from 15.0% to 18.0%. For shareholders, the quarter shows higher revenue and a GAAP profit, alongside lower FFO, which the company's own release treats as a key REIT operating measure.
Net income attributable to common stockholders was $0.24 per diluted share in Q3 2026, versus a loss of $0.56 per share in Q3 2025, helped by a $38.3 million gain on sale of real estate investments.
Nareit FFO was $0.13 per diluted share, down 43.5% year-over-year; Normalized FFO was $0.19 per diluted share, down 29.6%.
SHOP Same Store Cash NOI grew 13.6% year-over-year, and full-year 2026 SHOP guidance was raised to 16.5% to 18.5%.
The company redeemed its 7.375% Series A and 7.125% Series B preferred stock in September and October 2026, and expects about $11 million in annual preferred dividend savings.
SandRidge reported third-quarter 2026 net income of $30.6 million, or $0.83 per basic share, up from $16.0 million a year earlier, on revenue up 37% to $54.4 million and production up 10%. Net income includes a $14.2 million income tax benefit, and the company's adjusted net income was $23.8 million, or $0.64 per basic share, versus $0.42 a year earlier. The Board also declared a $0.13 per share dividend payable November 30, 2026, and the company reported no outstanding term or revolving debt as of September 30, 2026.
Third-quarter net income of $30.6 million, or $0.83 per basic share, versus $16.0 million, or $0.44 per basic share, in the third quarter of 2025
Adjusted net income of $23.8 million, or $0.64 per basic share, versus $15.5 million, or $0.42 per share, a year earlier
Revenue of $54.4 million, up 37% from $39.8 million; realized oil price fell to $85.27 per barrel from $95.35 in the second quarter
Dividend of $0.13 per share declared November 3, 2026, payable November 30, 2026 to holders of record on November 19, 2026; cash balance was $70.0 million on September 30, 2026
On November 4, 2026, WEC Energy Group entered into an equity distribution agreement allowing it to sell up to $4 billion of common stock through a group of sales agents and forward purchasers. The company expects to receive proceeds only when shares are sold and settled under forward sale agreements, and no proceeds are received from borrowed shares sold initially, so the program could dilute existing shareholders as shares are issued.
Maximum aggregate sales price under the Equity Distribution Agreement is $4 billion of common stock, $0.01 par value.
Sales agents include Barclays, BofA Securities, Citigroup, Goldman Sachs, J.P. Morgan, Morgan Stanley and Wells Fargo, among others.
Company will not initially receive proceeds from borrowed shares sold by forward sellers; proceeds come at later physical settlement.
On November 4, 2026, STERIS and its subsidiaries entered a new $1.6 billion revolving credit facility that replaces the existing credit agreement dated October 7, 2024, and a separate delayed draw term loan of up to $500 million. The term loan can be drawn only if STERIS completes its acquisition of Xodus Medical, Inc. For shareholders, the filing adds committed borrowing capacity tied to that acquisition, and the filing does not state the acquisition price or the amount that will be borrowed.
Revolving credit facility of $1,600 million matures on November 4, 2031, with an incremental increase of up to $800 million available.
Delayed draw term loan of up to $500 million can be used only after the Xodus Medical Acquisition is consummated and terminates if that deal is validly terminated or the outside date occurs.
Term loan matures five years after the acquisition closing date; no principal is due in year one, then 1.25% quarterly in years two and three and 1.875% quarterly in years four and five.
No borrowings were incurred to refinance the existing credit agreement at closing, and all term loan lenders are also lenders under the revolver.
FatPipe reported fiscal second-quarter 2027 results for the period ended September 30, 2026. Revenue grew 22% year over year, and the company swung to net income of $1.2 million from a loss of $0.04 million a year earlier, which points to a clear improvement in both sales and profit.
Q2 2027 revenue was $4.83 million, up from $3.96 million in Q2 2026
Net income was $1.2 million, compared with a loss of $0.04 million in Q2 2026
Diluted earnings per share were $0.09, versus $0.00 a year earlier
Adjusted EBITDA was $1.2 million, an approximate 24.1% margin, compared with $0.7 million in Q2 2026
Chord Energy reported third-quarter 2026 results, with net income of $181.6 million ($3.29 per diluted share) compared with $130.1 million ($2.26) a year earlier, though below the $525.2 million reported in the second quarter. The company raised its full-year 2026 oil volume guidance and expects Adjusted Free Cash Flow to be about $200 million higher than in August, while also announcing a $550.0 million gross Marcellus divestiture expected to close in the fourth quarter.
Net income was $181.6 million ($3.29 per diluted share) in Q3 2026, up from $130.1 million ($2.26) in Q3 2025 and down from $525.2 million in Q2 2026.
FY26 oil volume midpoint guidance increased about 1% from 161.0 to 162.5 MBopd; FY26 Adjusted Free Cash Flow expectations rose about $200 million since the August outlook.
The company repurchased $205.0 million of shares in Q3 2026 and another $78 million in Q4 2026 through October 30, 2026, and declared a base dividend of $1.30 per share payable December 7, 2026.
Marcellus non-operated assets are being divested for total gross consideration of $550.0 million, with closing expected in Q4 2026.
Evommune entered an exclusive license for Hinova Pharmaceuticals' VAV1 degraders, including EVO570, for all indications outside Greater China, paying a $20.0 million upfront cash payment plus warrants valued at $10.0 million. The company also agreed to sell 4,966,889 shares at $6.04 per share in a private placement expected to bring in gross proceeds of about $30 million, and estimates that cash plus these proceeds will fund operations into the second half of 2029.
License: $20.0 million upfront cash and pre-funded warrants for up to 1,262,413 shares, plus up to $150.0 million in development and regulatory milestones and up to $920.0 million in commercial milestones
Private placement: 4,966,889 shares at $6.04 per share, expected gross proceeds of about $30 million, expected to close on or about November 6, 2026
Company estimates pro forma cash of approximately $292.3 million, sufficient into the second half of 2029
Investors must file a Form S-3 resale registration within 60 days of closing
At a November 3, 2026 special meeting, NOVAGOLD shareholders approved the Arrangement Resolution, with 99.72% of votes cast in favor. The transaction would make New NOVAGOLD the parent company, with NOVAGOLD acquiring Paulson's 40% Donlin Gold interest and raising its ownership from 60% to 100%. Completion is expected in the fourth quarter of 2026, subject to regulatory, stock exchange and court approvals, and the equity plan drew 37.22% opposition.
Arrangement Resolution: 302,610,350 votes for (99.72%) and 380,548 against (0.13%).
2026 Omnibus Incentive Plan: 189,929,461 votes for (62.59%) and 112,946,575 against (37.22%).
Quorum of 303,446,751 shares, or 69.15% of 438,815,994 outstanding as of the September 23, 2026 record date.
Upon closing, holders of NOVAGOLD shares would own about 65% of New NOVAGOLD, and Paulson about 39.7% including existing stake.
On November 4, 2026, Kimberly-Clark settled exchange offers under which holders of Kenvue notes, assumed after its merger with Kenvue, exchanged them for new Kimberly-Clark notes with the same rates and maturities. The amendments removed substantially all restrictive covenants from the Kenvue notes still outstanding, so the financing terms for shareholders change mainly through the new Kimberly-Clark debt and the reduced protections for remaining Kenvue noteholders.
Settlement date was November 4, 2026; exchange offers expired November 2, 2026
Kimberly-Clark issued seven series of notes, with accepted principal ranging from $702,706,000 (4.850% notes due 2032) to $1,478,073,000 (5.050% notes due 2053)
Early participants received $970 principal of new notes, a $30 premium and $1.00 cash per $1,000 Kenvue notes tendered
Kimberly-Clark notes are general, unsecured senior obligations ranking equally with its existing unsecured senior debt
Ellington Financial reported net income attributable to common stockholders of $40.4 million, or $0.31 per share, for the quarter ended September 30, 2026, down from $54.4 million, or $0.43 per share, in the second quarter. Adjusted Distributable Earnings were $58.0 million, or $0.45 per share, and book value per common share was $13.53, which the company said exceeded its $0.39 quarterly dividend in adjusted earnings. For shareholders, the lower GAAP profit reflected a sharp drop in Longbridge segment earnings and losses in Corporate/Other.
Net income attributable to common stockholders was $40.4 million, or $0.31 per share, versus $54.4 million, or $0.43 per share, in Q2 2026.
Adjusted Distributable Earnings were $58.0 million, or $0.45 per share; the investment portfolio segment contributed $77.6 million.
Longbridge segment net income fell to $12.5 million from $30.2 million in the second quarter.
Issued $150 million of 7.375% senior unsecured notes due 2030 in September, bringing the series to $550 million outstanding.
Applied Optoelectronics entered a new Credit Agreement on October 30, 2026, with East West Bank as administrative agent, providing $30 million in revolving commitments and $170 million in initial term loan commitments. The company terminated its prior $35 million unused-revolver facility with BOK Financial on October 29, 2026, paying a $350,000 termination fee; the new facility matures October 30, 2030 and is secured by substantially all company assets.
New Credit Agreement dated October 30, 2026: $30 million revolving commitments and $170 million initial term loan commitments
Incremental term loan commitments of up to $50 million available subject to certain conditions
Prior Loan and Security Agreement dated July 31, 2025 terminated October 29, 2026; $350,000 termination fee paid
New facility matures October 30, 2030 and is secured by substantially all company assets
FRP Holdings reported a net loss attributable to the company of $165,000, or $(0.01) per share, for the quarter ended September 30, 2026, compared with net income of $662,000, or $0.03 per share, a year earlier. Total revenues rose 1.7% to $11.0 million, helped by a 10% increase in mining royalty revenue, but pro rata net operating income fell 5% to $9.0 million as multifamily and industrial results declined.
Q3 2026 net loss attributable to the company of $165,000, or $(0.01) per share, versus net income of $662,000, or $0.03 per share, in Q3 2025
Total revenues of $11.0 million, up 1.7%; mining royalty revenue rose 10%
Pro rata NOI fell 5% to $9.0 million; multifamily pro rata NOI fell 12% to $4.0 million
Nine-month net loss of $1,111,000, or $(0.06) per share, versus net income of $2,950,000 in the first nine months of 2025
Old National Bancorp furnished third-quarter 2026 investor presentation materials under Item 7.01, with the deck attached as Exhibit 99.1. The company reported record net income of $254 million and diluted EPS of $0.66, up from $0.65 in the prior quarter and $0.46 a year earlier, while repurchasing $100 million of common stock.
Net income of $254 million; net income applicable to common shares of $250 million, compared with $179 million a year earlier
Diluted EPS of $0.66 versus $0.65 in 2Q26 and $0.46 in 3Q25; adjusted EPS of $0.66, up 12% year over year
Repurchased $100 million, or 3.9 million shares, of common stock; $177 million of authorization remaining
Tangible book value per share was $13.77 at September 30, 2026, down from $14.32 at June 30, 2026
Viemed reported record third-quarter 2026 net revenue of $80.7 million, up 12.2% from a year earlier, and net income attributable to the company of $4.6 million, or $0.11 per diluted share, versus $0.09 a year earlier. It raised the low end of its 2026 revenue guidance to $316 million to $320 million but lowered the top of its Adjusted EBITDA range to $64 million to $66 million from $64 million to $68 million, so shareholders see higher revenue and profit alongside a narrower EBITDA outlook.
Q3 2026 net revenue $80.7 million, up $8.8 million or 12.2% year over year
Net income attributable to Viemed $4.6 million, or $0.11 per diluted share, versus $0.09 in Q3 2025
Adjusted EBITDA $17.1 million, up 5.8% year over year, with a margin of 21.1% of net revenue
2026 guidance: revenue $316 million to $320 million (low end raised from $314 million); Adjusted EBITDA $64 million to $66 million (high end lowered from $68 million)
On November 4, 2026, FTC Solar resumed use of its at-the-market offering program and executed common stock sales under it that day. The company had said in its September 30, 2026 quarterly report that it had no current plans to use the remaining capacity, and it says that statement no longer reflects its plans.
Sales of common stock were executed under the ATM Program on November 4, 2026, under a sales agreement dated May 1, 2025 with H.C. Wainwright & Co., LLC.
The 10-Q for the quarter ended September 30, 2026 said there were no current plans to use the remaining ATM capacity; the company now says that no longer reflects its plans.
The company says future sales depend on market conditions and that it is under no obligation to sell additional shares.
The filing states that any sales may be at prices that cause additional dilution to existing stockholders.
On October 29, 2026, PodcastOne, its majority parent LiveOne, and subsidiary guarantors entered into a Forbearance Agreement with holders of LiveOne's 11.75% senior secured convertible debentures. The lenders agreed not to exercise remedies for certain Events of Default that may have occurred, in exchange for cash payments, a fee in PodcastOne shares, and a new exit fee. The share issuance adds to the common stock outstanding, and the filing indicates the debt remains in default-related negotiations.
PodcastOne issued 275,000 common shares to the holders in a private placement as a fee for the forbearance
LiveOne must pay $1,000,000 within 30 days and $1,250,000 within 60 days of October 29, 2026
Exit fee of the greater of $1,000,000 or 1.5% of Company Sale Proceeds above $50,000,000, payable on maturity or a Company Sale
PodcastOne must file a resale registration statement within 30 days; late filing triggers payments of 2% per 30 days, up to 4%
On October 29, 2026, LiveOne and certain subsidiaries entered a Forbearance Agreement and Amendment to Debentures with holders of its 11.75% senior secured convertible debentures issued May 19, 2025. The holders agreed to forbear from exercising remedies for an existing Event of Default, but the company must make $1,000,000 and $1,250,000 payments and faces a contingent exit fee tied to a sale of PodcastOne. The filing adds new cash obligations and a default-related arrangement that shareholders should weigh.
Forbearance covers Event of Default under Section 7(a)(iii) of each debenture occurring before October 29, 2026; it ends on a Forbearance Termination Event or full payment of the obligations.
Company must pay $1,000,000 within 30 days and $1,250,000 within 60 days of the October 29, 2026 Effective Date.
November 2026 Holder Redemption Amount is deferred to December 15, 2026; redemption rights resume in December 2026.
PodcastOne issued 275,000 shares to the holders as a fee; an exit fee equal to the greater of $1,000,000 or 1.5% of PodcastOne sale proceeds above $50,000,000 applies on a PodcastOne sale.
Peapack Private Bank & Trust filed a complaint in New York State Supreme Court, Queens County, demanding repayment of all amounts outstanding under Fly-E Group's revolving credit facility. The lender seeks at least $3.9 million in principal plus interest, fees and possession of the collateral securing the debt, which could weigh on the company's finances and operations.
Complaint filed October 30, 2026, against the company, two subsidiaries as co-borrowers, corporate guarantors and two individual guarantors, including CEO Zhou Ou
Lender seeks at least $3.9 million in outstanding principal, plus accrued interest at a post-forbearance rate of 15.375% per annum, default interest, late charges and attorneys' fees
Credit facility matured August 31, 2025; forbearance agreement, amended May 28, 2026, ran through June 30, 2026; lender demanded collateral on October 20, 2026
The company said it is reviewing the complaint and evaluating its defenses and other available responses
Service Properties Trust reported a third-quarter 2026 net loss of $87.9 million, or $0.68 per share, compared with a $46.9 million loss a year earlier, and total revenues fell to $399.5 million from $478.8 million. The company also cut its midpoint full-year 2026 Normalized FFO guidance by $0.13 per share and said its board unanimously rejected an unsolicited, non-binding $2.0 billion proposal from TKO to buy its hotel portfolio, which the board believes undervalues the portfolio.
Q3 2026 net loss of $87.9 million, or $0.68 per share, versus a $46.9 million loss in Q3 2025
Q3 2026 Normalized FFO of $0.34 per share, versus $1.02 in Q3 2025; the company said this exceeded consensus estimates
Full-year 2026 Normalized FFO guidance lowered to $1.07 to $1.22 per share from $1.20 to $1.35
In October 2026 the board rejected TKO's unsolicited $2.0 billion proposal for the hotel portfolio
CF Industries reported third-quarter 2026 results in a presentation dated November 4, 2026, filed as Exhibit 99.1, and will discuss them on a conference call on November 5, 2026. Net sales, net earnings and adjusted EBITDA all rose from the third quarter of 2025, which is the main measure shareholders would watch.
Q3 2026 net sales were $1,860 million, up from $1,659 million in Q3 2025
Q3 2026 net earnings attributable to common stockholders were $436 million, or $2.87 per diluted share, versus $353 million, or $2.19 per diluted share, a year earlier
Q3 2026 adjusted EBITDA was $833 million, up from $667 million; nine-month 2026 adjusted EBITDA was $3,008 million versus $2,072 million
As of September 30, 2026, $1.1 billion remained under the current $2 billion share repurchase authorization, which runs through 2029
Great Elm Group reported fiscal first-quarter results for the period ended September 30, 2026. Revenue fell to $3.3 million from $10.8 million a year earlier, which included a $7.4 million property sale, while the net loss narrowed to $4.1 million from $7.0 million, mainly due to smaller investment losses.
Revenue was $3.3 million versus $10.8 million in the prior-year quarter; the prior year included about $7.4 million from a build-to-suit property sale.
Net loss attributable to stockholders was $4.1 million, or $0.14 per share, compared with $7.0 million, or $0.24 per share, a year earlier.
Adjusted EBITDA was a loss of $0.9 million versus a loss of $0.5 million in the prior-year period.
Cash and cash equivalents were $43.2 million at September 30, 2026; the company repurchased about 8.4 million shares through October 30, 2026, with $23.2 million of remaining program capacity.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.